Cytomegalovirus Active Infection in Critically Ill Children.
Journal
The Pediatric infectious disease journal
ISSN: 1532-0987
Titre abrégé: Pediatr Infect Dis J
Pays: United States
ID NLM: 8701858
Informations de publication
Date de publication:
01 10 2023
01 10 2023
Historique:
medline:
22
9
2023
pubmed:
31
7
2023
entrez:
31
7
2023
Statut:
ppublish
Résumé
To describe the epidemiology, clinical characteristics and outcomes of children with cytomegalovirus (CMV) active infection in the pediatric intensive care unit (PICU) and to investigate risk factors for mortality. This was a retrospective cohort study of patients who had CMV DNA detected in blood samples and/or tracheal aspirates by polymerase chain reaction (PCR) during stay at 2 PICUs of a university hospital. Suspected cases without etiological confirmation and patients with laboratory-confirmed CMV infection before PICU admission were excluded. Demographic, clinical and outcome data were collected from medical records. From January 1, 2012, to December 31, 2019, 4748 children were admitted to the PICUs. Thirty-five (0.74%; 95% CI 0.51%-1.02%) had laboratory-confirmed CMV active infection; 71.4% were immunocompromised and 11 (31.4%) died. Patients who died were older than those who survived (median age 65 vs. 5.5 months, respectively; P = 0.048), and they received antiviral therapy for a shorter time (median 12 vs. 23 days, respectively; P = 0.001). The main causa mortis was septic shock (82%) and in most deceased patients (73%) the last CMV PCR before death was positive. PELOD score >6 was a risk factor for death (RR 2.96; 95% CI 1.07-8.21). Viral load in blood had a poor ability for the prediction of death (area under the receiver operating characteristic curve 0.62; 95% CI 0.37-0.84). The incidence of CMV active infection during PICU stay was 0.74% in an upper-middle income country with a high CMV seroprevalence. PELOD score higher than 6 was a risk factor for death. No association was observed between CMV viral load and mortality.
Identifiants
pubmed: 37523581
doi: 10.1097/INF.0000000000004027
pii: 00006454-202310000-00008
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
875-882Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to disclose.
Références
Zuhair M, Smit GSA, Wallis G, et al. Estimation of the worldwide seroprevalence of cytomegalovirus: a systematic review and meta-analysis. Rev Med Virol. 2019;29:e2034.
de Mello AL, Ferreira EC, Vilas Boas LS, et al. Cytomegalovirus infection in a day-care center in the municipality of São Paulo. Rev Inst Med Trop Sao Paulo. 1996;38:165–169.
Wang YQ, Zhao XY. Human cytomegalovirus primary infection and reactivation: insights from virion-carried molecules. Front Microbiol. 2020;11:1511.
Alyazidi R, Murthy S, Slyker JA, et al. The potential harm of cytomegalovirus infection in immunocompetent critically ill children. Front Pediatr. 2018;6:96.
Lachance P, Chen J, Featherstone R, et al. Association between cytomegalovirus reactivation and clinical outcomes in immunocompetent critically ill patients: a systematic review and meta-analysis. Open Forum Infect Dis. 2017;4:ofx029.
Limaye AP, Kirby KA, Rubenfeld GD, et al. Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA. 2008;300:413–422.
Li X, Huang Y, Xu Z, et al. Cytomegalovirus infection and outcome in immunocompetent patients in the intensive care unit: a systematic review and meta-analysis. BMC Infect Dis. 2018;18:289.
Kalil AC, Florescu DF. Prevalence and mortality associated with cytomegalovirus infection in nonimmunosuppressed patients in the intensive care unit. Crit Care Med. 2009;37:2350–2358.
Solomon R, Mastropietro CW. Prolonged recovery from pediatric cardiac surgery due to disseminated cytomegalovirus infection. Congenit Heart Dis. 2013;8:E73–E76.
Hasegawa T, Oshima Y, Yamamoto M, et al. Fatal cytomegalovirus infection following cardiac surgery in a neonate with asplenia. Pediatr Int. 2016;58:1367–1368.
Choudhary A, Mehta A. Cytomegalovirus infection presenting as severe sepsis, hepatitis, and autoimmune hemolytic anemia in an immunocompetent child in pediatric intensive care unit. Pediatr Infect Dis J. 2021;40:e453–e454.
Pollack MM, Ruttimann UE, Getson PR. Pediatric risk of mortality (PRISM) score. Crit Care Med. 1988;16:1110–1116.
Leteurtre S, Martinot A, Duhamel A, et al. Validation of the paediatric logistic organ dysfunction (PELOD) score: prospective, observational, multicentre study. Lancet. 2003;362:192–197.
Cohen E, Kuo DZ, Agrawal R, et al. Children with medical complexity: an emerging population for clinical and research initiatives. Pediatrics. 2011;127:529–538.
Feudtner C, Feinstein JA, Zhong W, et al. Pediatric complex chronic conditions classification system version 2: updated for ICD-10 and complex medical technology dependence and transplantation. BMC Pediatr. 2014;14:199.
World Health Organization. Body mass index-for-age. Available at: https://www.who.int/toolkits/child-growth-standards/standards/body-mass-index-for-age-bmi-for-age . Accessed March 1, 2023.
Govender K, Jeena P, Parboosing R. Clinical utility of bronchoalveolar lavage cytomegalovirus viral loads in the diagnosis of cytomegalovirus pneumonitis in infants. J Med Virol. 2017;89:1080–1087.
Bline KE, Hall MW. Immune function in critically ill septic children. Pathogens. 2021;10:1239.
Razonable RR, Hayden RT. Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation. Clin Microbiol Rev. 2013;26:703–727.
Limaye AP, Boeckh M. CMV in critically ill patients: pathogen or bystander? Rev Med Virol. 2010;20:372–379.
Chou S, Kim DY, Scott KM, et al. Immunoglobulin M to cytomegalovirus in primary and reactivation infections in renal transplant recipients. J Clin Microbiol. 1987;25:52–55.
Pass RF, Griffiths PD, August AM. Antibody response to cytomegalovirus after renal transplantation: comparison of patients with primary and recurrent infections. J Infect Dis. 1983;147:40–46.
Wirgart BZ, Claesson K, Eriksson BM, et al. Cytomegalovirus (CMV) DNA amplification from plasma compared with CMV pp65 antigen (ppUL83) detection in leukocytes for early diagnosis of symptomatic CMV infection in kidney transplant patients. Clin Diagn Virol. 1996;7:99–110.